Literature DB >> 19864594

Cupressaceae pollen grains modulate dendritic cell response and exhibit IgE-inducing adjuvant activity in vivo.

Seiji Kamijo1, Toshiro Takai, Takatoshi Kuhara, Tomoko Tokura, Hiroko Ushio, Mikiko Ota, Norihiro Harada, Hideoki Ogawa, Ko Okumura.   

Abstract

Pollen is considered a source of not only allergens but also immunomodulatory substances, which could play crucial roles in sensitization and/or the exacerbation of allergies. We investigated how allergenic pollens from different plant species (Japanese cedar and Japanese cypress, which belong to the Cupressaceae family, and birch, ragweed, and grass) modulate murine bone marrow-derived dendritic cell (DC) responses and examined the effect of Cupressaceae pollen in vivo using mice. DCs were stimulated with pollen extracts or grains in the presence or absence of LPS. Cell maturation and cytokine production in DCs were analyzed by flow cytometry, ELISA, and/or quantitative PCR. Pollen extracts suppressed LPS-induced IL-12 production and the effect was greatest for birch and grass. Without LPS, pollen grains induced DC maturation and cytokine production without IL-12 secretion and the response, for which TLR 4 was dispensable, was greatest for the Cupressaceae family. Intranasal administration of Cupressaceae pollen in mice induced an elevation of serum IgE levels and airway eosinophil infiltration. Coadministration of ovalbumin with Cupressaceae pollen grains induced ovalbumin-specific IgE responses associated with eosinophil infiltration. The results suggest that modulation of DC responses by pollen differs among the plant families via (1) the promotion of DC maturation and cytokine production by direct contact and/or (2) the inhibition of IL-12 production by soluble factors. The strong DC stimulatory activity in vitro and IgE-inducing activity in mice support the clinical relevance of Cupressaceae pollen to allergies in humans.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19864594     DOI: 10.4049/jimmunol.0901039

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Murine allergic rhinitis and nasal Th2 activation are mediated via TSLP- and IL-33-signaling pathways.

Authors:  Shoko Akasaki; Kazufumi Matsushita; Yukinori Kato; Ayumi Fukuoka; Naruhito Iwasaki; Masakiyo Nakahira; Shigeharu Fujieda; Koubun Yasuda; Tomohiro Yoshimoto
Journal:  Int Immunol       Date:  2015-10-01       Impact factor: 4.823

Review 2.  Innate responses to pollen allergens.

Authors:  Koa Hosoki; Istvan Boldogh; Sanjiv Sur
Journal:  Curr Opin Allergy Clin Immunol       Date:  2015-02

3.  Effect of Oreodoxa oleracea Jacq. pollen protein allergen in albino mice.

Authors:  Dimphna Nneka Ezikanyi; Happiness Oselebe
Journal:  Postepy Dermatol Alergol       Date:  2020-09-02       Impact factor: 1.837

4.  Context matters: TH2 polarization resulting from pollen composition and not from protein-intrinsic allergenicity.

Authors:  Lorenz Aglas; Stefanie Gilles; Renate Bauer; Sara Huber; Galber R Araujo; Geoffrey Mueller; Sandra Scheiblhofer; Marie Amisi; Hieu-Hoa Dang; Peter Briza; Barbara Bohle; Jutta Horejs-Hoeck; Claudia Traidl-Hoffmann; Fatima Ferreira
Journal:  J Allergy Clin Immunol       Date:  2018-05-18       Impact factor: 10.793

Review 5.  The Role of Lipids in Development of Allergic Responses.

Authors:  Manuel Gómez Del Moral; Eduardo Martínez-Naves
Journal:  Immune Netw       Date:  2017-06-20       Impact factor: 6.303

6.  Birch Pollen Induces Toll-Like Receptor 4-Dependent Dendritic Cell Activation Favoring T Cell Responses.

Authors:  Lisa Pointner; Amin Kraiem; Michael Thaler; Fabian Richter; Mario Wenger; Athanasios Bethanis; Markus Klotz; Claudia Traidl-Hoffmann; Stefanie Gilles; Lorenz Aglas
Journal:  Front Allergy       Date:  2021-08-12

Review 7.  Do lipids influence the allergic sensitization process?

Authors:  Merima Bublin; Thomas Eiwegger; Heimo Breiteneder
Journal:  J Allergy Clin Immunol       Date:  2014-05-28       Impact factor: 10.793

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.